Virtus Investment Advisers, LLC

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 19481 HARTFORD, CT

Back to BCRX Full portfolio

Position in BCRX

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$1,336,640

+$274,884 QoQ

Shares Held

133,664

+19.8% QoQ

Ownership

0.052%

of shares outstanding

% of Portfolio

0.31%

of 13F equity value

Holder Rank

#110

of 316 holders

Holding Since

Sep 2022

8 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Common Shares in BCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Virtus Investment Advisers, LLC holds $9,997,407 across 9 Drug Manufacturers - Specialty & Generic names. BCRX ranks #4 (13.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KNSA	Kiniksa Pharmaceuticals International, plc	22,411	$1,433,183
2	XERS	Xeris Biopharma Holdings, Inc.	171,264	$1,356,410
3	IRWD	Ironwood Pharmaceuticals Inc	318,598	$1,341,297
4	BCRX	Biocryst Pharmaceuticals Inc This page	133,664	$1,336,640
5	LQDA	Liquidia Corp	16,326	$1,301,671
6	NBIX	Neurocrine Biosciences Inc	7,279	$1,226,802
7	UTHR	UNITED THERAPEUTICS Corp	2,130	$1,154,097
8	BIOA	BioAge Labs, Inc.	18,137	$444,537

All Filings in BCRX

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,336,640	133,664	+19.8%	Shares	Other	2026-08-11
2026-03-31	$1,061,756	111,529	+23.5%	Shares	Other	2026-05-14
2025-12-31	$704,168	90,278	+111.3%	Shares	Other	2026-02-17
2025-09-30	$324,320	42,730	0.0%	Shares	Other	2025-11-14
2025-06-30	$382,860	42,730	-9.5%	Shares	Other	2025-08-13
2025-03-31	$354,292	47,239	+97.6%	Shares	Other	2025-05-15
2022-12-31	$274,486	23,910	-42.7%	Shares	Other	2023-02-14
2022-09-30	$525,520	41,708	—	Shares	Other	2022-11-14
No filing history on record for this holder in this stock.